Kinfo
Medicus Pharma Ltd. logo

Medicus Pharma Ltd.

MDCXNASDAQHealthcare·US · USD
$1.89
+0.01 (+0.80%)
Prices as of November 9, 2026 · market closed

Price

Key statistics

Valuation
Market cap3.58M USD
Enterprise value8.86M USD
Trailing P/E-0.69
Forward P/E-0.08
PEG ratio0.01
Price / sales0.00
Price / book-60.16
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-110.67%
Return on equity-7446.11%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA0.00 USD
Net income-56.66M USD
Diluted EPS-$119.00
Rev. growth (YoY)0.00%
Balance sheet
Total cash15.17M USD
Total debt21.64M USD
Debt / equity-12.54
Current ratio1.57
Book value / share-$0.13
Cash flow (TTM)
Operating cash flow-29.32M USD
Levered free cash flow-16.16M USD
Shares & price
Shares outstanding56.66M
Float1.06M
Held by institutions3.35%
Beta0.15
50-day MA$6.14
200-day MA$21.19
52-week high$127.50
52-week low$1.70
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-11-06-6.50-11.64−79.08%2026-08-12-8.00-10.50−31.25%2026-07-090.03-0.03−200.00%2026-05-120.680.70+2.94%
About Medicus Pharma Ltd.

Medicus Pharma Ltd. is a biotech and life sciences company focused on advancing precision-guided therapeutic assets through clinical development programs. The company’s current portfolio centers on novel treatments in dermatology and oncology, including SkinJect, a localized immuno-oncology product being developed for non-melanoma skin diseases such as basal cell carcinoma and Gorlin syndrome. It is also developing Teverelix, a next-generation GnRH antagonist being studied for prostate cancer, acute urinary retention related to enlarged prostate, and endometriosis. Medicus Pharma Ltd. works as a clinical-stage developer, supporting research, trial activity, and regulatory progress for specialized drug candidates aimed at difficult-to-treat conditions. Headquartered in Canada with operations in the United States, the company plays a focused role in the life sciences market by advancing targeted therapies from development through clinical evaluation.

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Dr. Raza Bokhari M.B.A., M.D.
Employees
16
Headquarters
West Conshohocken, PA, United States

Frequently asked questions about Medicus Pharma Ltd.